Drug companies have become frustrated with the newly revamped EudraVigilance database, which they claim is forcing them to waste time needlessly trawling through hundreds of individual case safety reports (ICSRs).
Since the updated database was launched last November, the number of ICSRs that companies are having to assess has increased...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?